Open AccessPrimary platinum resistance and its prognostic impact in patients with recurrent ovarian cancer: an analysis of three prospective trials from the NOGGO study group
Author(s) -
Fabian Trillsch,
Sven Mahner,
Bastian Czogalla,
Miriam Rottmann,
Radoslav Chekerov,
Elena Ioana Braicu,
Gülten Oskay-Öczelik,
Pauline Wimberger,
Rolf Richter,
Jalid Sehouli
Publication year - 2021
Publication title -
journal of gynecologic oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.358
H-Index - 37
eISSN - 2005-0399
pISSN - 2005-0380
DOI - 10.3802/jgo.2021.32.e37
Subject(s) - medicine , hazard ratio , oncology , sorafenib , chemotherapy , bevacizumab , prospective cohort study , progression free survival , proportional hazards model , gastroenterology , confidence interval , hepatocellular carcinoma